You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Litigation Details for Netlist, Inc. v. Samsung Electronics Co, LTD (E.D. Tex. 2022)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Netlist, Inc. v. Samsung Electronics Co, LTD

Litigation Summary and Analysis for Netlist, Inc. v. Samsung Electronics Co., LTD | 2:22-cv-00293

Last updated: August 13, 2025

Introduction

The patent infringement case of Netlist, Inc. v. Samsung Electronics Co., LTD, filed in the United States District Court for the District of Delaware (D. Del.), bears significant implications within the semiconductor and storage industry. As a strategic litigation effort, Netlist alleges Samsung infringed on its patents related to memory module and system architecture, seeking injunctive relief and damages. This detailed analysis explores the case's procedural history, legal assertions, locus of dispute, and strategic implications for stakeholders, with particular emphasis on patent law and current industry dynamics.

Case Overview

Filed on February 16, 2022, Netlist accuses Samsung of infringing several patents, notably U.S. Patent Nos. 9,695,312 and 10,988,533, which elaborate on non-volatile memory architecture and module design. The dispute signals ongoing tensions over advanced memory technologies in the era of cloud computing, big data, and high-performance computing ecosystems.

Netlist’s patents cover innovations in Hybrid Memory Modules (HMM), integrating DRAM and NAND flash memory, which enhance performance and scalability in enterprise systems. Samsung, a major player in the DRAM and NAND markets, faces allegations of unauthorized use of patented technology within its industry-leading memory modules.

Procedural History

  • Complaint Filing: February 16, 2022, asserting patent infringement, seeking a permanent injunction, monetary damages, and attorneys’ fees.
  • Initial Motions: Samsung filed a motion to dismiss in June 2022, contesting patent validity and non-infringement.
  • Claim Construction: The court conducted a Markman hearing in September 2022, pivotal for defining key claim terms.
  • Discovery Phase: Began late 2022, including exchanges of technical documents, depositions, and expert reports.
  • Expert Reports: Filed in early 2023, focusing on infringement analysis and patent validity, framing the dispute’s technical core.
  • Current Status: As of the latest update (mid-2023), the case is in discovery, with scheduled pre-trial conferences.

Legal Claims and Allegations

Patent Infringement

Netlist contends Samsung's memory modules incorporate patented architectures without licensing, breaching 35 U.S.C. § 271. The core allegations include:

  • Unauthorized copying of unique hybrid memory configurations.
  • Use of claimed circuit architectures in Samsung’s high-density DIMMs and SSDs.
  • Indirect infringement through supply of infringing components to OEMs.

Patent Validity

Samsung counters that the patents are invalid based on prior art, obviousness, or failure to meet patentability criteria under 35 U.S.C. § 102-103. The validity dispute plays a key role in the litigation, with both parties submitting extensive prior art references.

Injunctive and Damages Claims

Netlist seeks injunctive relief preventing Samsung from further infringement. Damages are quantified based on lost profits and reasonable royalties, considering the economic impact on Netlist’s market share.

Technical Dispute

The essence of the legal contention hinges on technical definitions interpreted during claim construction. Critical issues include:

  • Memory Architecture Terminology: The scope of “hybrid memory module” claims.
  • Circuit Configuration: Whether Samsung’s memory chips embody the claimed circuit arrangements.
  • Infringement Analysis: The extent of direct and indirect infringement through supply and design.

The case’s technical complexity underscores the importance of expert testimony, patent claim interpretation, and detailed product analysis.

Strategic Significance

For Netlist

  • The litigation reinforces Netlist’s patent portfolio as a tool against industry giants.
  • Successful infringement findings could result in substantial damages or injunctive relief, influencing supply chains and product offerings.
  • The case exemplifies the enforceability of hybrid memory technology patents in high-stakes litigation.

For Samsung

  • The defense efforts aim to invalidate patents or limit their scope.
  • Samsung's broader strategy involves challenging patent validity via prior art defenses and seeking to sway claim interpretation in its favor.
  • It signals the importance of proactive patent portfolio management and competitive R&D investments to preempt infringement suits.

Industry Implications

This case highlights the growing significance of patent enforcement in the memory ecosystem, impacting OEMs, memory module manufacturers, and patent holders. The outcome could set precedents for future patent claims in high-tech memory innovations, influencing licensing policies and innovation strategies.

Legal and Industry Implications

  • Patent Strength and Enforcement: Demonstrates the critical importance of robust patent drafting and strategic enforcement.
  • Technical Expertise in Litigation: Emphasizes the necessity of deep technical understanding for successful patent litigation.
  • Market Dynamics: A potential injunction could disrupt supply lines, prompting industry shifts and alternative sourcing.

Potential Outcomes and Impact

  • Summary Judgment or Early Resolution: Given the case's complexity, early dispositive motions are unlikely, but negotiated settlement remains possible.
  • Infringement Affirmed: Could lead to injunctions and licensing negotiations, impacting market competition.
  • Patent Invalidity: A ruling favoring Samsung may weaken Netlist’s patent portfolio and influence similar patent battles.

Conclusion

The Netlist v. Samsung case embodies the intersection of patent law, technological innovation, and competitive strategy within the memory industry. Its progression underscores the significance of patent enforcement in safeguarding intellectual property rights amid rapid technological evolution. Its resolution promises to influence industry practices, patent strategies, and innovation pathways for years to come.


Key Takeaways

  • Patent litigation in high-tech sectors can profoundly shape market dynamics and technological development.
  • Clear claim construction and expert technical analysis are vital in determining infringement validity.
  • Patent validity defenses, including prior art and obviousness challenges, are pivotal in shaping legal outcomes.
  • Strategic patent enforcement requires balancing litigation costs against potential market leverage.
  • Outcomes in such cases can catalyze industry-wide licensing trends and innovation priorities.

FAQs

Q1: What are the primary patents at issue in Netlist v. Samsung?
A1: The case centers on U.S. Patent Nos. 9,695,312 and 10,988,533, which relate to hybrid memory modules and system architectures designed for high-performance storage solutions.

Q2: How does claim interpretation affect the outcome in this case?
A2: Claim construction defines the scope of patent protection; a narrow interpretation favors Samsung, potentially invalidating infringement claims, while a broad interpretation supports Netlist’s allegations.

Q3: What implications does this case have for the memory industry?
A3: It emphasizes the importance of robust patent portfolios, proactive enforcement, and technical innovation, influencing licensing and R&D strategies.

Q4: What are common defenses Samsung might raise?
A4: Samsung likely relies on prior art references to challenge patent validity, non-infringement arguments based on technical non-conformity, and possible inequitable conduct claims.

Q5: What is the significance of the ongoing discovery process?
A5: Discovery allows both parties to gather technical and legal evidence, shaping potential settlement negotiations or setting the stage for dispositive motions and trial.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.